Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125833401 | 12583340 | 1 | I | 20160714 | 20160722 | 20160722 | EXP | US-009507513-1607USA007554 | MERCK | 0.00 | F | Y | 0.00000 | 20160722 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125833401 | 12583340 | 1 | PS | INTRON A | INTERFERON ALFA-2B | 1 | UNK | 103132 | POWDER FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125833401 | 12583340 | 1 | Mycosis fungoides |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125833401 | 12583340 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125833401 | 12583340 | Abdominal pain | |
125833401 | 12583340 | Amnesia | |
125833401 | 12583340 | Anaemia | |
125833401 | 12583340 | Anxiety | |
125833401 | 12583340 | Arthralgia | |
125833401 | 12583340 | Back pain | |
125833401 | 12583340 | Chest pain | |
125833401 | 12583340 | Cognitive disorder | |
125833401 | 12583340 | Constipation | |
125833401 | 12583340 | Cough | |
125833401 | 12583340 | Depression | |
125833401 | 12583340 | Diarrhoea | |
125833401 | 12583340 | Dizziness | |
125833401 | 12583340 | Dyspnoea | |
125833401 | 12583340 | Dyspnoea exertional | |
125833401 | 12583340 | Dysuria | |
125833401 | 12583340 | Ear congestion | |
125833401 | 12583340 | Epistaxis | |
125833401 | 12583340 | Fatigue | |
125833401 | 12583340 | Gingival bleeding | |
125833401 | 12583340 | Haematochezia | |
125833401 | 12583340 | Haematuria | |
125833401 | 12583340 | Headache | |
125833401 | 12583340 | Increased tendency to bruise | |
125833401 | 12583340 | Insomnia | |
125833401 | 12583340 | Loss of consciousness | |
125833401 | 12583340 | Mass | |
125833401 | 12583340 | Maternal exposure during pregnancy | |
125833401 | 12583340 | Melaena | |
125833401 | 12583340 | Mood swings | |
125833401 | 12583340 | Mouth ulceration | |
125833401 | 12583340 | Muscular weakness | |
125833401 | 12583340 | Myalgia | |
125833401 | 12583340 | Nausea | |
125833401 | 12583340 | Odynophagia | |
125833401 | 12583340 | Oedema | |
125833401 | 12583340 | Orthopnoea | |
125833401 | 12583340 | Palpitations | |
125833401 | 12583340 | Product use issue | |
125833401 | 12583340 | Pruritus | |
125833401 | 12583340 | Pruritus generalised | |
125833401 | 12583340 | Seizure | |
125833401 | 12583340 | Sensory loss | |
125833401 | 12583340 | Skin ulcer | |
125833401 | 12583340 | Temperature intolerance | |
125833401 | 12583340 | Trichorrhexis | |
125833401 | 12583340 | Vertigo | |
125833401 | 12583340 | Vision blurred | |
125833401 | 12583340 | Vomiting | |
125833401 | 12583340 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |